Literature DB >> 2124710

Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.

T A Owen1, R Bortell, S A Yocum, S L Smock, M Zhang, C Abate, V Shalhoub, N Aronin, K L Wright, A J van Wijnen.   

Abstract

Osteocalcin, a bone-specific protein and marker of the mature osteoblast, is expressed only in nonproliferating osteoblasts in a mineralizing extracellular matrix, while type I collagen is expressed in proliferating cells. The nuclear proteins encoded by the c-fos and c-jun protooncogenes are expressed during the proliferation period of osteoblast phenotype development. We present evidence that AP-1 (HeLa cell-activating protein 1) sites residing within two promoter elements of the osteocalcin gene bind the Fos-Jun protein complex: the osteocalcin box (OC box; nucleotides -99 to -76), which contains a CCAAT motif as a central element and influences tissue-specific basal levels of osteocalcin gene transcription, and the vitamin D-responsive element (VDRE; nucleotides -462 to -440), which mediates enhancement of osteocalcin gene transcription. Gel electrophoretic mobility-shift analysis demonstrated high AP-1 binding activity in proliferating osteoblasts and dramatic changes in this activity after the down-regulation of proliferation and the initiation of extracellular-matrix mineralization in primary cultures of normal diploid osteoblasts. Methylation interference analysis established at single nucleotide resolution that purified recombinant Fos and Jun proteins bind in a sequence-specific manner to the AP-1 sites within the VDRE and OC box. Similarly, an AP-1 motif within a putative VDRE of the alkaline phosphatase gene, which is also expressed after the completion of proliferation, binds the Fos-Jun complex. These results support a model in which coordinate occupancy of the AP-1 sites in the VDRE and OC box in proliferating osteoblasts may suppress both basal level and vitamin D-enhanced osteocalcin gene transcription as well as transcription of other genes associated with osteoblast differentiation--a phenomenon we describe as phenotype suppression. This model is further supported by binding of the Fos-Jun complex at an AP-1 site in the type alpha I collagen promoter that is contiguous with, but not overlapping, the VDRE. Such a sequence organization in the collagen VDRE motif is compatible with vitamin D modulation of collagen but not with osteocalcin and alkaline phosphatase expression in proliferating osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124710      PMCID: PMC55300          DOI: 10.1073/pnas.87.24.9990

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix.

Authors:  T A Owen; M Aronow; V Shalhoub; L M Barone; L Wilming; M S Tassinari; M B Kennedy; S Pockwinse; J B Lian; G S Stein
Journal:  J Cell Physiol       Date:  1990-06       Impact factor: 6.384

2.  V-fos stimulates expression of the alpha 1(III) collagen gene in NIH 3T3 cells.

Authors:  C Setoyama; A Hatamochi; B Peterkofsky; W Prather; B de Crombrugghe
Journal:  Biochem Biophys Res Commun       Date:  1986-05-14       Impact factor: 3.575

3.  Isolation and characterization of the rat alpha 1(I) collagen promoter. Regulation by 1,25-dihydroxyvitamin D.

Authors:  A Lichtler; M L Stover; J Angilly; B Kream; D W Rowe
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

4.  Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression.

Authors:  J Lian; C Stewart; E Puchacz; S Mackowiak; V Shalhoub; D Collart; G Zambetti; G Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  The role of the leucine zipper in the fos-jun interaction.

Authors:  T Kouzarides; E Ziff
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

6.  Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40.

Authors:  W Lee; A Haslinger; M Karin; R Tjian
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

7.  Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.

Authors:  A Schönthal; P Herrlich; H J Rahmsdorf; H Ponta
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

8.  Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3.

Authors:  K G Yoon; S J Rutledge; R F Buenaga; G A Rodan
Journal:  Biochemistry       Date:  1988-11-15       Impact factor: 3.162

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Common DNA binding site for Fos protein complexes and transcription factor AP-1.

Authors:  F J Rauscher; L C Sambucetti; T Curran; R J Distel; B M Spiegelman
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

View more
  33 in total

Review 1.  The biology and pathology of vitamin D control in bone.

Authors:  Taison D Bell; Marie B Demay; Sherri-Ann M Burnett-Bowie
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

2.  Sequence-specific DNA binding by the alphaNAC coactivator is required for potentiation of c-Jun-dependent transcription of the osteocalcin gene.

Authors:  Omar Akhouayri; Isabelle Quélo; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

3.  Retinoic acid is a negative regulator of AP-1-responsive genes.

Authors:  R Schüle; P Rangarajan; N Yang; S Kliewer; L J Ransone; J Bolado; I M Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  The mouse Pgk-1 gene promoter contains an upstream activator sequence.

Authors:  M W McBurney; L C Sutherland; C N Adra; B Leclair; M A Rudnicki; K Jardine
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

Review 5.  Tissue specific and vitamin D responsive gene expression in bone.

Authors:  C White; E Gardiner; J Eisman
Journal:  Mol Biol Rep       Date:  1998-01       Impact factor: 2.316

6.  Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex.

Authors:  A Caricasole; A Ward
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

7.  Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.

Authors:  T K Kerppola; D Luk; T Curran
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 8.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

9.  An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene.

Authors:  C Banerjee; S W Hiebert; J L Stein; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.

Authors:  F W Thalacker; M Nilsen-Hamilton
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.